Article Contents ::
- 1 Details Descriptions About :: Alzheimer S Disease
- 2 Alzheimer’s disease is a progressive degenerative disorder of the cerebral cortex, especially the frontal lobe. It affects approximately 4 million Americans; by 2040, that figure may exceed 6 million. Age Alert Alzheimer’s disease typically affects adults older than age 60, but some cases have been reported in individuals as young as in their late 30s. The disease has a poor prognosis. Typically, the duration of illness is 8 years, and patients die 2 to 5 years after onset of debilitating brain symptoms.
- 3 Causes for Alzheimer S Disease
- 4 Pathophysiology Alzheimer S Disease
- 5 Signs and symptoms Alzheimer S Disease
- 6 Diagnostic Lab Test results
- 7 Treatment for Alzheimer S Disease
- 8 Disclaimer ::
- 9 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details Descriptions About :: Alzheimer S Disease
Alzheimer’s disease is a progressive degenerative disorder of the cerebral cortex, especially the frontal lobe. It affects approximately 4 million Americans; by 2040, that figure may exceed 6 million. Age Alert Alzheimer’s disease typically affects adults older than age 60, but some cases have been reported in individuals as young as in their late 30s. The disease has a poor prognosis. Typically, the duration of illness is 8 years, and patients die 2 to 5 years after onset of debilitating brain symptoms.
Causes for Alzheimer S Disease
Causes Exact cause unknown Possible contributing factors Genetic patterns Beta-amyloid plaque development Inflammatory and oxidative stress processes The role of estrogen in the brain
Pathophysiology Alzheimer S Disease
Pathophysiology The brain of a patient with Alzheimer’s disease has three characteristic features: neurofibrillary tangles (fibrous proteins), neuritic plaques (composed of degenerating axons and dendrites), and neuronal loss (degeneration). Neurofibrillary tangles are bundles of filaments found inside neurons that abnormally twist around one another. Abnormally phosphorylated tau proteins accumulate in the neurons as the characteristic tangles and ultimately cause neuronal death. In a healthy brain, tau provides structural support for neurons, but in patients with Alzheimer’s disease this structural support collapses. Neuritic plaques (senile plaques) form outside the neurons in the adjacent brain tissue. Plaques contain a core of beta-amyloid protein surrounded by abnormal nerve endings or neurites. Overproduction or decreased metabolism of beta-amyloid peptide leads to a toxic state causing degeneration of neuronal processes, neuritic plaque formation, and eventually neuronal loss and clinical dementia. Tangles and plaques cause neurons in the brain of the patient with Alzheimer’s disease to shrink and eventually die, first in the memory and language centers and finally throughout the entire brain. This widespread neuron degeneration leaves gaps in the brain’s messaging network that may interfere with communication between cells, causing some of the symptoms of Alzheimer’s disease.
Signs and symptoms Alzheimer S Disease
Signs and symptoms Mild Disorientation to date Impaired recall Diminished insight Irritability Apathy Moderate Increased disorientation (time and place) Fluent aphasia Difficulties with comprehension Impaired recognition Poor judgment Trouble performing activities of daily living (ADLs) Aggression Restlessness Psychosis Sleep disturbances Dysphoria Severe Unable to use language appropriately Memory only to the moment Needs assistance with all ADLs Urinary and fecal incontinence
Diagnostic Lab Test results
Diagnostic test results Neuropsychologic evaluation shows deficits in memory, reasoning, vision-motor coordination, and language function. Magnetic resonance imaging or computed tomography scan reveals brain atrophy at later stages of the disease. Positron emission tomography scanning shows decreased brain activity. EEG shows evidence of slowed brain waves at later stages of the disease.
Treatment for Alzheimer S Disease
Treatment Cholinesterase inhibitors, such as tacrine, donepezil, rivastigmine, and galantamine Behavioral therapy Nonsteroidal anti-inflammatory drugs Cholesterol-lowering drugs Estrogen